Erratum
After publication of this work [1], it was noted that co-author Sahar Tahvili was inadvertently missed from the author list. This has been corrected here, and in the original article. The publisher would like to apologize for any inconvenience this oversight may have caused.
Reference
Deronic A, Tahvili S, Leanderson T, Ivars F. The anti-tumor effect of the quinoline-3-carboxamide tasquinimod: blockade of recruitment of CD11b + Ly6Chi cells to tumor tissue reduces tumor growth. BMC Cancer. 2016;16:440. doi:10.1186/s12885-016-2481-0.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found under doi:10.1186/s12885-016-2481-0.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Deronic, A., Tahvili, S., Leanderson, T. et al. Erratum to: The anti-tumor effect of the quinoline-3-carboxamide tasquinimod: blockade of recruitment of CD11b+ Ly6Chi cells to tumor tissue reduces tumor growth. BMC Cancer 16, 610 (2016). https://doi.org/10.1186/s12885-016-2649-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12885-016-2649-7